Iloperidone (Fanapt): an FDA-approved treatment option for schizophrenia.

Autor: Montes AB, Rey JA

Publikováno v: P&T: A Peer-Reviewed Journal for Managed Care & Formulary Management; 2009 Nov, Vol. 34 Issue 11, p606-613, 5p

A General Method for Solvent Exchange of Plasmonic Nanoparticles and Self-Assembly into SERS-Active Monolayers.

Autor: Serrano-Montes AB; CIC biomaGUNE, Paseo de Miramón 182, 20009 Donostia-San Sebastián, Spain., Jimenez de Aberasturi D; CIC biomaGUNE, Paseo de Miramón 182, 20009 Donostia-San Sebastián, Spain., Langer J; CIC biomaGUNE, Paseo de Miramón 182, 20009 Donostia-San Sebastián, Spain., Giner-Casares JJ; CIC biomaGUNE, Paseo de Miramón 182, 20009 Donostia-San Sebastián, Spain., Scarabelli L; CIC biomaGUNE, Paseo de Miramón 182, 20009 Donostia-San Sebastián, Spain., Herrero A; CIC biomaGUNE, Paseo de Miramón 182, 20009 Donostia-San Sebastián, Spain., Liz-Marzán LM; CIC biomaGUNE, Paseo de Miramón 182, 20009 Donostia-San Sebastián, Spain.; Ikerbasque, Basque Foundation for Science, 48013 Bilbao, Spain.

Publikováno v: Langmuir : the ACS journal of surfaces and colloids [Langmuir] 2015 Aug 25; Vol. 31 (33), pp. 9205-13. Date of Electronic Publication: 2015 Aug 14.

Evaluation of oro-facial function in young subjects with temporomandibular disorders.

Autor: Kobayashi FY; Department of Pediatric Dentistry, Piracicaba Dental School, University of Campinas-UNICAMP, Piracicaba, Brazil., Gavião MB, Montes AB, Marquezin MC, Castelo PM

Publikováno v: Journal of oral rehabilitation [J Oral Rehabil] 2014 Jul; Vol. 41 (7), pp. 496-506. Date of Electronic Publication: 2014 Mar 24.

Expression of the metalloproteases MMP-1, MMP-2, MMP-3, MMP-9, MMP-11, TIMP-1 and TIMP-2 in angiocentric midfacial lymphomas.

Autor: Meneses-García A; Pathology department, Instituto Nacional de Cancerología, Mexico., Betancourt AM, Abarca JH, Montes AB, Roa LS, Ruíz-Godoy L

Publikováno v: World journal of surgical oncology [World J Surg Oncol] 2008 Oct 27; Vol. 6, pp. 114. Date of Electronic Publication: 2008 Oct 27.